Royal Bank Of Canada Cytokinetics Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Cytokinetics Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 17,126 shares of CYTK stock, worth $894,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,126

Previous 3,180 438.55%

Holding current value

$894,319

Previous $172,000 425.58%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $714,314 - $838,991	13,946 Added 438.55%	17,126 $904,000
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $674,490 - $1.06 Million	-14,093 Reduced 81.59%	3,180 $172,000
Q1 2024 Nov 05, 2024	BUY	$63.75 - $108.06 $898,428 - $1.52 Million	14,093 Added 443.18%	17,273 $1.21 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $457,661 - $775,762	-7,179 Reduced 29.36%	17,273 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $597,623 - $1.86 Million	22,233 Added 1001.94%	24,452 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $1,266 - $1,574	43 Added 1.98%	2,219 $65,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $148,910 - $186,023	-4,565 Reduced 67.72%	2,176 $70,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $276,387 - $378,707	-8,285 Reduced 55.14%	6,741 $237,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $433,711 - $619,708	12,125 Added 417.96%	15,026 $688,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $78,467 - $111,002	-2,036 Reduced 41.24%	2,901 $140,000
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $63,449 - $91,480	-1,870 Reduced 27.47%	4,937 $194,000
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $296,359 - $458,390	-9,965 Reduced 59.41%	6,807 $250,000
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $223,034 - $301,145	6,493 Added 63.17%	16,772 $764,000
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $34,428 - $66,369	1,857 Added 22.05%	10,279 $367,000
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $166,671 - $227,309	8,422 New	8,422 $167,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Cytokinetics Inc Transaction History